Longevity in Anti-VEGF Inhibitors Utilized in AMD/DME

Retina specialists discuss 2-year data updates in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials for wet macular degeneration (wet AMD) and diabetic macular edema (DME).